The Hydration Pharmaceuticals Company Ltd (hpc) Logo

The Hydration Pharmaceuticals Company Ltd (HPC)

___:___ · Consumer Defensive

HPC Chart


HPC's Principal Activity is the the marketing and sale of liquid, tablet and powder hydration solution products into the North American markets of Canada and the United States.

Share Price Activity

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume (4w avg)
Day Range -
Prev Close
Last Trade


1 Week
1 Month
2022 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -30.43%


Market Capitalisation
ASX Rank 1,547 of 2,400
Sector Rank 55 of 95

Key Fundamentals

Shares Issued
Sector Consumer Defensive
Similar Companies CLB / KTD / TFL
EPS $0.00
DPS $0.00
NTA per share $0.00

Broker Consensus

HPC is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.


Date Heading Pages File Size Time

Corporate Overview

The Hydration Pharmaceuticals Company Limited (HPC) is a consumer products company that operates in the Healthy Hydration Solutions Market, which sits at the intersection of the Over-the-Counter Consumer Healthcare Market, the Functional Beverages Market and the Vitamin and Mineral Supplements Market.

Incorporation Details

No incorporation details available.

Corporate Details

Head Office San Diego CA USA 92121
Registry Automic Group
Auditor PricewaterhouseCoopers
Date Listed 14 Dec 2021

Upcoming Calendar (Forecasted)

No calendar entries available.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors & Management

Name Title Since Bio
Mr George Livery Non-Executive Chairman,Non-Executive Director Nov 2021

Mr George Livery

Non-Executive Chairman,Non-Executive Director

Mr Livery has more than 30 years of experience, both domestically and internationally. A C-level executive for the last 25 years, His career has included CEO of Village Cinemas Australia, COO of Village International, Commercial Director at Hoyts Ltd, Director of Operations (Non-Academic Services) at University of Sydney's USU, both Commercial Director at Swisse Vitamins and Director of Strategy & Corporate at Swisse Wellness Group. He also led the corporate integration of Swisse Wellness into the Hong Kong listed H&H Group of companies and enjoyed a dual role during that time as Group Senior VP Legal and Risk. He was also a Fellow of the Australia Marketing Institute. He was formerly executive chair, and is currently non-executive director, of ASX-listed Bod Australia Limited (ASX: BDA). He is currently non-executive chair of a private company called Buy Aussie Now. He is also a member of Risk and Compliance Committee.

Ms Gretta van Riel Non-Executive Director Nov 2021

Ms Gretta van Riel

Non-Executive Director

Ms van Riel is a serial entrepreneur, having founded five start-ups including SkinnyMe Tea, the 5TH Watches and Drop Bottle. She has experience in building and scaling eCommerce brands and is expert in influencer-led online marketing campaigns and brand development. She is a member of the Risk and Compliance Committee.

Mr Adem Karafili Non-Executive Director Oct 2018

Mr Adem Karafili

Non-Executive Director

Mr Karafili is currently the Executive Chairman of ASX-listed Top Shelf International Holdings Ltd. Prior to that, he spent seven years establishing Swisse Wellness before its sale to H&H Group (formerly Biostime International). He held senior positions of CFO, COO and MD at Swisse Wellness. Additionally, he currently chairs his private investment vehicle ANGLKorp and also chairs the 2030 Greater Victoria Commonwealth Games Taskforce, the National Institute of Integrated Medicine (NIIM) and sits on the investment committee for the private equity firm Corner Capital. She also chairs of the Risk and Compliance Committee.

Ms Carlie Hodges Company Secretary N/A
Mr Oliver Baker Chief Executive Officer N/A

Director Interests

The current holdings of HPC directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Gretta van Riel 02/11/2021 0 N/A N/A N/A
George Livery 02/11/2021 0 N/A N/A N/A
Adem Karafili 15/10/2018 N/A 1,560,417 1,974,739 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Dec 10, 2021.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Woobinda Nominees Pty Limited (The Woobinda Family A/C) 15,005,877 9.32%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 0 0 74 236 203 513

Substantial Shareholders

No Substantial Shareholders for HPC in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
14-12-21 Woobinda Nominees Pty Limited 15,005,877 -- 9.32
14-12-21 Radek Sali 12,314,437 -- 7.65
14-12-21 Regal Funds Management Pty Ltd 14,716,805 -- 9.14
29-11-21 PURE Asset Management Pty Ltd 8,359,580 -- 5.19

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
HPC Historical Price Data (CSV)
Up to 20 years of EOD share price history
You must be logged in to access this feature. Please sign up for free or login.
Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.